Alcohol Intervention Studies

Chamie G, Hahn JA, Kekibiina A, Emenyonu NI, Beesiga B, Marson K, Fatch R, Lodi S, Adong J, Thirumurthy H, McDonell MG. Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial. The Lancet Global Health. 2023 Dec 1;11(12):e1899-910.
 
Hahn JA, Fatch R, Emenyonu NI, Sanyu N, Katusiime A, Levine B, Boscardin WJ, Chander G, Hutton H, Camlin CS, Woolf-King SE. Effect of two counseling interventions on self-reported alcohol consumption, alcohol biomarker phosphatidylethanol (PEth), and viral suppression among persons living with HIV (PWH) with unhealthy alcohol use in Uganda: A randomized controlled trial. Drug and alcohol dependence. 2023 Mar 1;244:109783.
 
Puryear, S.B., Mwangwa, F., Opel, F., Chamie, G., Balzer, L.B., Kabami, J., Ayieko, J., Owaraganise, A., Kakande, E., Agengo, G. and Bukusi, E., 2023. Effect of a brief alcohol counselling intervention on HIV viral suppression and alcohol use among persons with HIV and unhealthy alcohol use in Uganda and Kenya: a randomized controlled trial. Journal of the International AIDS Society, 26(12), p.e26187.
 
Kane JC, Allen I, Fatch R, Scheffler A, Emenyonu N, Puryear SB, Chirayil P, So-Armah K, Kahler CW, Magidson JF, Conroy AA. Efficacy of alcohol reduction interventions among people with HIV as evaluated by self-report and a phosphatidylethanol (PEth) outcome: protocol for a systematic review and individual participant data meta-analysis. BMJ open. 2023 Jun 1;13(6):e070713.
 
Edelman EJ, Dziura J, Deng Y, DePhilippis D, Fucito LM, Ferguson T, Bedimo R, Brown S, Marconi VC, Goetz MB, Rodriguez-Barradas MC. Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trial. Contemporary Clinical Trials. 2023 Aug 1;131:107242.
 
Parry CD, Myers B, Londani M, Shuper PA, Nkosi S, Hahn JA, Kekwaletswe C, Morojele NK. Self‐reported alcohol use versus phosphatidylethanol in behavioral trials: A study of people living with HIV in Tshwane, South Africa. Alcoholism: Clinical and Experimental Research. 2023 May;47(5):940-50.
 
Fraser ER, Hill-Kapturczak N, Jett J, Beck R, Oluwoye O, Kriegel LS, Alcover KC, McPherson S, Cabassa LJ, Javors M, McDonell MG. Mixed-methods trial of a phosphatidylethanol-based contingency management intervention to initiate and maintain alcohol abstinence in formerly homeless adults with alcohol use disorders. Contemporary Clinical Trials Communications. 2021 Jun 1;22:100757.
 
McDonell MG, Leickly E, McPherson S, Skalisky J, Srebnik D, Angelo F, Vilardaga R, Nepom JR, Roll JM, Ries RK. A randomized controlled trial of ethyl glucuronide-based contingency management for outpatients with co-occurring alcohol use disorders and serious mental illness. American Journal of Psychiatry. 2017 Apr 1;174(4):370-7.